Belgium· BE-AMP-SAM660362-00
Camcevi 42 mg
A leuprorelin product containing leuprorelin mesilate, registered in Belgium by Accord Healthcare. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Leuprorelin is registered in 13 of 19 countries.
Countries holding a registration under ATC L02AE02 (leuprorelin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Leuprorelin · ATC L02AE02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of leuprorelin costs, country by country.
Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Leuprorelin · price per daily dose (1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$34.21
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Leuprorelin Mesilate
- Manufacturer
- Accord Healthcare
- Country
- Belgium (BE)
- ATC code
- L02AE02
- ATC class
- Leuprorelin
- Defined daily dose
- 1 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb4969234EUR 309.57
- be_apb7746639
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
320 interactions on record for leuprorelin.
Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Leuprorelin · interactions on record
320 records
- 69 severe
- 248 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Leuprorelin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCAMCEVIAccord Healthcare S.L.U., Barcelona
- SpainCAMCEVI 42 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADAAccord Healthcare S.L.U.
- United KingdomCamcevi 42mg prolonged-release suspension for injection pre-filled syringesAccord-UK Ltd
- IcelandCamceviAccord Healthcare S.L.U.
- PolandCamceviAccord Healthcare S.L.U.
- SwedenCamcevi 42 mg Injektionsvätska, depotsuspensionAccord Healthcare S.L.U.
- NetherlandsCAMCEVI 21 mg suspensie voor injectie met verlengde afgifteAccord Healthcare S.L.U.
- FinlandCAMCEVIAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Eligard Depot, Enantone Monats-Depot
- Bulgaria · Елигард, Лутрат Депо
- Cyprus · Eligard
- Czechia · Eligard, Leptoprol
- Germany · Eligard, Enantone Monats-Depot
- Denmark · Eligard, Leuprorelin Sandoz
- Estonia · Eligard
- Spain · Eligard Semestral, Eligard Trimestral
- Finland · Eligard, Enanton Depot Dual
- France · Eligard, Enantone Lp
- United Kingdom (Northern Ireland) · Prostap 3 Dcs, Prostap Pd Dcs
- Greece · Deplanda, Elityran
- Croatia · Eligard, Lerin
- Hungary · Eligard, Leuprorelin Pharmacenter
- Ireland · Eligard, Leuprex 3
- Iceland · Camcevi, Eligard
- Italy · Eligard, Enantone
- Liechtenstein · Camcevi
- Lithuania · Eligard
- Luxembourg · Depo-Eligard, Leugon
- Latvia · Eligard, Leptoprol
- Malta · Deplanda
- Netherlands · Eligard, Leuproreline Sandoz
- Norway · Camcevi, Eligard
- Poland · Eligard, Leuprostin
- Portugal · Eligard, Lutrate Depot
- Romania · Eligard, Leptoprol
- Sweden · Eligard, Enanton Depot Dual
- Slovenia · Eligard, Leptoprol
- Slovakia · Eligard, Leuprorelin Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/edaa2838-b1d9-4fb6-a79d-79d77c09a2c5 GET /v1/drugs/edaa2838-b1d9-4fb6-a79d-79d77c09a2c5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Prolonged-release suspension for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Camcevi 42 mg",
"name_fr": "Camcevi 42 mg",
"name_nl": "Camcevi 42 mg",
"amp_code": "SAM660362-00",
"strengths": [
"42.0000",
"42.0000"
],
"pack_count": 1,
"substances": [
"Leuprorelin Mesilate",
"Leuprorelin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Leuprorelin",
"authorisation_numbers": [
"EU/1/22/1647/001"
]
}See everything about leuprorelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.